These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 29725633)

  • 41. Clinical Value of Complement Activation Biomarkers in Overt Diabetic Nephropathy.
    Pelletier K; Bonnefoy A; Chapdelaine H; Pichette V; Lejars M; Madore F; Brachemi S; Troyanov S
    Kidney Int Rep; 2019 Jun; 4(6):797-805. PubMed ID: 31194090
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Therapeutic targeting of classical and lectin pathways of complement protects from ischemia-reperfusion-induced renal damage.
    Castellano G; Melchiorre R; Loverre A; Ditonno P; Montinaro V; Rossini M; Divella C; Battaglia M; Lucarelli G; Annunziata G; Palazzo S; Selvaggi FP; Staffieri F; Crovace A; Daha MR; Mannesse M; van Wetering S; Paolo Schena F; Grandaliano G
    Am J Pathol; 2010 Apr; 176(4):1648-59. PubMed ID: 20150432
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characteristics of diabetic nephropathy patients without diabetic retinopathy: A retrospective observational study.
    Li XQ; Zheng X; Chen M; Zhao MH
    Medicine (Baltimore); 2017 May; 96(18):e6805. PubMed ID: 28471980
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Progressive IgA Nephropathy Is Associated With Low Circulating Mannan-Binding Lectin-Associated Serine Protease-3 (MASP-3) and Increased Glomerular Factor H-Related Protein-5 (FHR5) Deposition.
    Medjeral-Thomas NR; Troldborg A; Constantinou N; Lomax-Browne HJ; Hansen AG; Willicombe M; Pusey CD; Cook HT; Thiel S; Pickering MC
    Kidney Int Rep; 2018 Mar; 3(2):426-438. PubMed ID: 29725647
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An autopsy study suggests that diabetic nephropathy is underdiagnosed.
    Klessens CQ; Woutman TD; Veraar KA; Zandbergen M; Valk EJ; Rotmans JI; Wolterbeek R; Bruijn JA; Bajema IM
    Kidney Int; 2016 Jul; 90(1):149-56. PubMed ID: 27165826
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diabetic retinopathy may predict the renal outcomes of patients with diabetic nephropathy.
    Zhang J; Wang Y; Li L; Zhang R; Guo R; Li H; Han Q; Teng G; Liu F
    Ren Fail; 2018 Nov; 40(1):243-251. PubMed ID: 29633887
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevalence and Management of Diabetic Nephropathy in Western Countries.
    Satirapoj B; Adler SG
    Kidney Dis (Basel); 2015 May; 1(1):61-70. PubMed ID: 27536666
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical and prognostic significance of glomerular C1q deposits in primary MN.
    Zhang MF; Cui Z; Zhang YM; Qu Z; Wang X; Wang F; Meng LQ; Cheng XY; Liu G; Zhao MH
    Clin Chim Acta; 2018 Oct; 485():152-157. PubMed ID: 29969623
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM; Mauer M;
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diabetic retinopathy is a poor predictor of type of nephropathy in proteinuric type 2 diabetic patients.
    Prakash J; Lodha M; Singh SK; Vohra R; Raja R; Usha
    J Assoc Physicians India; 2007 Jun; 55():412-6. PubMed ID: 17879494
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical characteristics and outcomes of biopsy-proven diabetic nephropathy.
    Zhuo L; Zhang N; Zou G; Chen D; Li W
    Front Med; 2017 Sep; 11(3):386-392. PubMed ID: 28871455
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Elevated levels of renal and circulating Nop-7-associated 2 (NSA2) in rat and mouse models of diabetes, in mesangial cells in vitro and in patients with diabetic nephropathy.
    Shahni R; Gnudi L; King A; Jones P; Malik AN
    Diabetologia; 2012 Mar; 55(3):825-34. PubMed ID: 22095236
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The clinicopathological characteristics of diabetic nephropathy and non-diabetic renal diseases in diabetic patients].
    Xu J; Hu XF; Huang W; Shen PY; Zhang W; Ren H; Li X; Wang WM; Chen N; Pan XX
    Zhonghua Nei Ke Za Zhi; 2017 Dec; 56(12):924-929. PubMed ID: 29202533
    [No Abstract]   [Full Text] [Related]  

  • 54. Importance of frequency and morphological characteristics of nodular diabetic glomerulosclerosis in diabetic nephropathy.
    Yasuda F; Mii A; Morita M; Aoki M; Tagawa M; Aratani S; Kaneko T; Sakai Y; Shimizu A
    Hum Pathol; 2018 May; 75():95-103. PubMed ID: 29408640
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Vitronectin in children with renal disease--1. Immunofluorescence study of vitronectin and C5b-9 in childhood IgA nephropathy].
    Takahashi T; Inaba S; Okada T
    Nihon Jinzo Gakkai Shi; 1995 Apr; 37(4):213-23. PubMed ID: 7541480
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Risk factors for the development of diabetic nephropathy].
    Antić M; Jotić A; Radović M; Seferović JP; Lalić NM; Jovanović D; Lezaić V
    Srp Arh Celok Lek; 2009; 137(1-2):18-26. PubMed ID: 19370961
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Glomerular expression of platelet-derived growth factor (PDGF)-A, -B chain and PDGF receptor-alpha, -beta in human diabetic nephropathy.
    Uehara G; Suzuki D; Toyoda M; Umezono T; Sakai H
    Clin Exp Nephrol; 2004 Mar; 8(1):36-42. PubMed ID: 15067514
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mannose-binding lectin activates the nuclear factor-κB and renal inflammation in the progression of diabetic nephropathy.
    Ma Y; Cai F; Huang X; Wang H; Yu B; Wang J; Nie W; Cai K; Yang Y; Chen J; Xiao L; Han F
    FASEB J; 2022 Mar; 36(3):e22227. PubMed ID: 35195918
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Renal histological lesions in patients with type II diabetes mellitus].
    Castellano I; Covarsí A; Novillo R; Gómez-Martino JR; Ferrando L
    Nefrologia; 2002; 22(2):162-9. PubMed ID: 12085417
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Correlation between cognitive impairment and diabetic nephropathy in patients with Type 2 diabetes mellitus].
    Shi X; Zhang Y; Niu H; Wang R; Shen J; Zhou S; Yang H; Wang S; Wu J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 41(2):143-50. PubMed ID: 26932211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.